The pervasive challenge of managing antipsychotic medication in long-term care settings has emerged as a critical concern in geriatric healthcare, drawing attention from policymakers, clinicians, and researchers alike. Recent research published in BMC Geriatrics by Wong et al. (2026) delves deeply into the labyrinthine barriers and facilitators that complicate or enable efforts to reduce inappropriate antipsychotic use in these vulnerable populations. This investigation offers a comprehensive scoping review, providing some of the most nuanced insights yet into why decades-old problems in medication management persist despite growing awareness and guidelines promoting more judicious prescribing practices.
Long-term care facilities globally cater to aging populations often marked by complex comorbidities, including dementia and behavioral symptoms wherein antipsychotics have been frequently prescribed. However, the efficacy and safety of these medications—originally intended for psychiatric conditions—are highly questionable in geriatric patients, given their association with increased risk of mortality, cognitive decline, and falls. Wong and colleagues’ review recognizes this dissonance and systematically explores the multifaceted obstacles that prevent healthcare systems from achieving optimal prescribing behaviors. The research highlights how ingrained clinical culture, systemic resource deficits, and regulatory landscapes intricately interplay in shaping antipsychotic use patterns.
One of the primary revelations from the study centers on clinical inertia—the reluctance or failure among healthcare providers to change established prescribing routines. This inertia is often anchored in a perceived lack of alternatives or insufficient training in non-pharmacological interventions. According to Wong et al., the reliance on antipsychotics as a “quick fix” for behavioral disturbances in individuals with dementia is symptomatic of broader systemic deficiencies, including inadequate staffing and limited access to specialized geriatric psychiatric expertise. These conditions foster an environment where antipsychotic prescriptions are sustained by a pragmatic, if medically unsound, rationale.
The review also underscores the profound impact of organizational and institutional policies on shaping medication practices. Facilities with strong leadership commitment to de-prescribing strategies, accompanied by continuous education and support for frontline caregivers, demonstrate markedly better outcomes in reducing inappropriate antipsychotic use. Conversely, where such leadership is absent or inconsistent, efforts often flounder amidst competing priorities and operational constraints. The authors point out that integrating evidence-based protocols within routine workflows is essential but remains challenging due to the complexity of care environments in long-term settings.
Regulatory frameworks emerge as another critical domain influencing antipsychotic prescribing patterns. The researchers identify variations in policy enforcement and surveillance as significant contributors to inconsistent implementation of prescribing guidelines. Some jurisdictions employ stringent monitoring and incentivize reductions, effectively driving down usage rates. In contrast, others lack robust oversight mechanisms, allowing old habits to persist unchecked. This disparity highlights the necessity of harmonizing regulatory approaches to create a standardized foundation upon which quality improvement initiatives can be reliably built.
The role of caregivers and family members, although often overlooked, features prominently in the review. The study captures how their perceptions, knowledge, and expectations about antipsychotic medications shape decision-making processes within care facilities. Education campaigns tailored to demystify medication risks and promote person-centered care options have shown promise in fostering collaborative environments conducive to medication optimization. Nevertheless, achieving such alignment requires sustained engagement and culturally sensitive communication strategies, as caregivers’ attitudes profoundly influence outcomes.
Non-pharmacological interventions, recognized worldwide as safer and more humane alternatives for managing behavioral symptoms, are identified as pivotal facilitators in reducing antipsychotic reliance. Techniques such as individualized behavioral therapy, environmental modifications, and sensory stimulation therapies yield significant benefits when appropriately resourced and implemented. The review highlights recurring barriers to their adoption, including time constraints, lack of trained personnel, and a paucity of institutional support. Enhancing workforce capacity and incentivizing innovation within care pathways are essential to translate these interventions from theory to widespread practice.
Technology is another emerging factor with potential to revolutionize medication management in long-term care. Wong et al. discuss how electronic health record systems, telepsychiatry, and real-time monitoring tools can aid clinicians in making data-driven prescribing decisions and tracking adverse effects promptly. Despite these promising developments, integration of technological solutions remains patchy. Addressing interoperability issues, ensuring user-friendly interfaces, and securing funding for digital infrastructure are identified as prerequisite steps toward realizing these benefits fully.
Furthermore, the authors emphasize the importance of multidisciplinary collaboration as a cornerstone for successful intervention. Engaging pharmacists, nurses, physicians, social workers, and allied health professionals in shared decision-making can break down silos and foster cohesive care models focused on minimizing inappropriate medication use. Such collaboration requires clear communication channels, joint training programs, and mutual respect among team members to overcome professional hierarchies and promote holistic approaches to care.
Cultural and contextual factors further complexify implementation efforts. The review acknowledges the diversity of care settings with varying resource levels, demographic profiles, and societal attitudes toward aging and mental health. Tailoring strategies to local needs and incorporating community values enhance acceptability and sustainability of interventions. Wong et al. advocate for adaptive frameworks that balance fidelity to evidence-based guidelines with flexibility to address unique challenges at the ground level.
Health economic considerations also feature prominently in the analysis. Inappropriate antipsychotic use incurs considerable costs related to adverse drug reactions, hospitalizations, and administrative burden. Conversely, investing in education, staffing, and alternative therapies entails upfront expenditures that can be politically and financially contentious. The review highlights the need for robust economic evaluations to inform policymakers and stakeholders about cost-benefit trade-offs, ultimately supporting evidence-based allocation of limited healthcare resources.
The scoping review conducted by Wong et al. represents an important step in mapping the terrain of implementing change within long-term care pharmacotherapy. It offers a roadmap valuably rich in technical detail and practical insights, emphasizing that reducing inappropriate antipsychotic use is not solely a clinical issue but a multifactorial challenge requiring systemic transformation. Echoing a call for coordinated action, it appeals to all actors within the health ecosystem to confront inertia, leverage facilitators, and creatively navigate obstacles in pursuit of safer, more dignified care for the elderly.
The findings have profound implications for future research directions, highlighting gaps such as the need for longitudinal studies evaluating intervention sustainability, more granular analyses of facility-level variables, and enhanced methodologies for capturing patient and caregiver outcomes comprehensively. Additionally, translational research bridging the divide between guideline development and real-world practice emerges as a critical frontier poised to accelerate progress.
Ultimately, as populations age worldwide and demand for long-term care escalates, addressing the inappropriate use of antipsychotic medications assumes ever-greater urgency. Wong et al.’s scoping review provides a clarion call and a blueprint for innovation, collaboration, and advocacy necessary to reform prescribing culture. In doing so, it envisions a future where the rights and well-being of the most vulnerable are safeguarded by enlightened, evidence-based care practices.
Subject of Research: Strategies to reduce inappropriate antipsychotic use in long-term care environments and the associated barriers and facilitators of implementation.
Article Title: Barriers and facilitators to implementing strategies for reducing inappropriate antipsychotic use in long-term care: a scoping review
Article References:
Wong, K.L.Y., Hung, L., Wong, J.O.Y. et al. Barriers and facilitators to implementing strategies for reducing inappropriate antipsychotic use in long-term care: a scoping review. BMC Geriatr (2026). https://doi.org/10.1186/s12877-026-07263-7
Image Credits: AI Generated
Tags: antipsychotic medication management in geriatricsantipsychotic risks in elderly patientsbarriers to deprescribing antipsychoticschallenges in long-term care prescribingclinical inertia in medication managementdementia behavioral symptom managementfacilitators for safer antipsychotic usegeriatric pharmacotherapy optimizationinappropriate antipsychotic use reductionregulatory impact on antipsychotic prescribingstrategies for reducing antipsychotic overusesystemic resource limitations in long-term care
